These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9216708)

  • 1. Effects of 5'-DFUR and OK-432 on cytokines and thymidine phosphorylase in tumor tissue of gastric cancer patients.
    Ohwada S; Ogawa T; Izumi M; Inoue T; Teshigawara O; Ikeya T; Kusaba T; Roppongi T; Iino Y; Morishita Y
    Anticancer Res; 1997; 17(3C):2313-8. PubMed ID: 9216708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intratumoral OK-432 administration of thymidine phosphorylase expression in human gastric carcinoma.
    Ogawa K; Konno S; Takebayashi Y; Murayama M; Shimakawa T; Katsube T; Naritaka Y; Kajiwara T; Aiba M; Akiyama S
    Anticancer Res; 2001; 21(2B):1257-62. PubMed ID: 11396196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of intratumor administration of OK-432 on the tumor selectivity of 5'-DFUR].
    Ogawa K; Katsube T; Konno S; Miura K; Wakasugi S; Watanabe T; Shimakawa T; Ishikawa S; Naritaka Y; Yagawa H
    Gan To Kagaku Ryoho; 1995 Dec; 22(14):2095-100. PubMed ID: 8607621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymidine phosphorylase activity in transitional cell cancer: relation to histological parameters and chemosensitivity to fluorouracil-related drugs.
    Hirano Y; Kageyama S; Ushiyama T; Suzuki K; Fujita K
    Anticancer Res; 2000; 20(6B):4315-8. PubMed ID: 11205264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of 5'-deoxy-5-fluorouridine (5'-DFUR) on the activity of pyrimidine nucleoside phosphorylase (pyNPase) in normal and tumor tissues of human stomach].
    Kimura T; Kobayashi T; Nakaya Y; Iida T; Uchimura M; Murohisa B; Nagashima T; Matsumoto Y; Kitamura H; Shibata M
    Gan To Kagaku Ryoho; 1995 Jul; 22(8):1051-6. PubMed ID: 7611757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis induced by preoperative oral 5'-DFUR administration in gastric adenocarcinoma and its mechanism of action.
    Zhao WH; Wang SF; Ding W; Sheng JM; Ma ZM; Teng LS; Wang M; Wu FS; Luo B
    World J Gastroenterol; 2006 Mar; 12(9):1356-61. PubMed ID: 16552801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymidine phosphorylase activity in renal cell carcinoma: relationship between histological parameters and chemosensitivity to fluorouracil-related drugs.
    Hirano Y; Takayama T; Kageyama S; Ushiyama T; Suzuki K; Fujita K
    Urol Res; 2002 May; 30(2):112-5. PubMed ID: 12086015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of gastric carcinoma treated effectively with 5'-DFUR].
    Gotoh M; Takiuchi H; Hirata I; Iyama M; Inoue R; Itabashi T; Egashira Y; Inoue T; Kurisu Y; Tanaka M; Shimamoto C; Katsu K
    Gan To Kagaku Ryoho; 1999 May; 26(6):837-9. PubMed ID: 10410155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5'-deoxy-5-fluorouridine.
    Eda H; Fujimoto K; Watanabe S; Ura M; Hino A; Tanaka Y; Wada K; Ishitsuka H
    Cancer Chemother Pharmacol; 1993; 32(5):333-8. PubMed ID: 8339382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation between pyrimidine nucleoside phosphorylase (PyNPase)/thymidine phosphorylase/platelet-derived endothelial cell growth factor and histological prognostic factor, and influence of 5'-deoxy-5-fluorouridine (5'-DFUR) administration on PyNPase activities and serum immunosuppressive acidic protein levels. A study group of oral anti-cancer drugs in Seiban/Tajima area].
    Satoh B; Ohtoshi M; Ishida Y; Hen-mi K; Kaneko I; Soda M; Sugihara J; Shibagaki F; Iwai N; Nakamura T; Yamasaki T; Matsumoto S
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):359-64. PubMed ID: 9492829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 5'-DFUR and lentinan on cytokines and PyNPase against AH66 ascites hepatoma in rats.
    Ogawa T; Ohwada S; Sato Y; Izumi M; Nakamura S; Takeyoshi I; Kawashima Y; Ohya T; Koyama T; Morishita Y
    Anticancer Res; 1999; 19(1A):375-9. PubMed ID: 10226570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes of cytokine levels in ascitic fluid after intraperitoneal administration of OK-432 or CDDP].
    Terashima M; Takagane A; Abe K; Kuboi M; Asahi H; Saito K
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2326-9. PubMed ID: 7944471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled study of immunochemotherapy with OK-432 after curative surgery for gastric cancer.
    Sato Y; Kondo M; Kohashi S; Takahashi N; Takahashi S; Sinohara T; Ono K; Matsuda M; Ryoma Y; Shiroto H; Kondo Y; Uchino J; Saito K; Todo S
    J Immunother; 2004; 27(5):394-7. PubMed ID: 15314548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.
    Yamaguchi Y; Ohshita A; Kawabuchi Y; Hihara J; Miyahara E; Noma K; Toge T
    Int J Oncol; 2004 Apr; 24(4):959-66. PubMed ID: 15010836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation between pyrimidine nucleoside phosphorylase (PyNPase)/platelet-derived endothelial cell growth factor and histological prognostic factor, and influences of 5'-deoxy-5-fluorouridine (5'-DFUR) administration on PyNPase levels. 5'-DFUR Joint Research Group in the Osaka Area for Gastric Cancer].
    Yamasaki Y; Kuwata K; Hioki K; Sowa M; Hirakawa K; Okajima K; Isozaki H; Iwanaga T; Furukawa H; Nakano H; Watanabe A; Takami M; Tsukahara Y; Matsunaga S; Kikkawa N; Gotoh T; Tokuda H; Takahashi S; Toyohara M; Yagi M; Takebayashi J; Nakajima T; Miyazaki H; Kuwata H; Nakazato H
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1549-56. PubMed ID: 9725048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of response to 5'-deoxy-5-fluorouridine (5'-DFUR) in patients with inoperable advanced gastric cancer by immunostaining of thymidine phosphorylase/platelet-derived endothelial cell growth factor.
    Koizumi W; Saigenji K; Nakamaru N; Okayasu I; Kurihara M
    Oncology; 1999 Apr; 56(3):215-22. PubMed ID: 10202277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Successful treatment of hepatic metastasis of gastric cancer with 5'-DFUR and Lentinan].
    Takita M; Onda M; Tokunaga A; Shirakawa T; Ikeda K; Hiramoto Y; Teramoto T; Oguri T; Fujita I; Okuda T; Mizutani T; Kiyama T; Yoshiyuki T; Matsukura N
    Gan To Kagaku Ryoho; 1998 Jan; 25(1):129-33. PubMed ID: 9464340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymidine phosphorylase activity in human bladder cancer: difference between superficial and invasive cancer.
    Kubota Y; Miura T; Moriyama M; Noguchi S; Matsuzaki J; Takebayashi S; Hosaka M
    Clin Cancer Res; 1997 Jun; 3(6):973-6. PubMed ID: 9815773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymidine phosphorylase expression correlates with malignant potential and anti-tumor effect of doxifluridine on gastric cancer: multivariate analysis for adjuvant chemotherapy doxifluridine vs. 5-fluorouracil.
    Takiguchi N; Ishii R; Koda K; Oda K; Miyazaki M
    Oncol Rep; 2003; 10(5):1105-11. PubMed ID: 12883665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in transitional cell cancer.
    Hirano Y; Kageyama S; Ushiyama T; Suzuki K; Fujita K
    Cancer Chemother Pharmacol; 2003 Jan; 51(1):29-35. PubMed ID: 12497203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.